LILRB1 and neoplasm: In line with these observations, Mendel et al., for example, demonstrated that inhibition of ILT2 (preventing HLA-G from acting via ILT2) restores antitumor immune response leading to decreased tumor growth, less metastatic spread, and a prolonged survival in a humanized mouse model (52).